Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS · Delayed Price · Currency is USD
2.800
+0.050 (1.82%)
At close: Jul 11, 2025
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $4.50 million as of August 6, 2025. Its market cap has decreased by -90.25% in one year.
Market Cap
4.50M
Enterprise Value
6.99M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.80
Market Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 4.50M, a decrease of -93.29%. That is a compound annual growth rate of -43.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 4.50M | -11.11% |
| Dec 17, 2024 | 5.06M | -16.78% |
| Dec 27, 2023 | 6.08M | -4.15% |
| Dec 29, 2022 | 6.34M | -66.00% |
| Dec 30, 2021 | 18.65M | -57.38% |
| Dec 31, 2020 | 43.76M | -34.67% |
| Oct 20, 2020 | 66.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| CytoDyn | 366.82M |